Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cai, W.
Right arrow Articles by Chen, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cai, W.
Right arrow Articles by Chen, X.
Related Collections
Right arrow Tumor Biology
Right arrow Tumor Biology: Model Organisms and Imaging
Mol Cancer Ther. 2006;5:2624-2633
© 2006 American Association for Cancer Research

Drug Development Series: Review

How molecular imaging is speeding up antiangiogenic drug development

Weibo Cai1, Jianghong Rao1, Sanjiv S. Gambhir1,2 and Xiaoyuan Chen1

1 The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program and 2 Department of Bioengineering, Stanford University School of Medicine, Stanford, California

Requests for reprints: Xiaoyuan Chen, The Molecular Imaging Program at Stanford, Department of Radiology and Bio-X Program, Stanford University School of Medicine, 1201 Welch Road, P095, Stanford, CA 94305-5484. Phone: 650-725-0950; Fax: 650-736-7925. E-mail: shawchen{at}stanford.edu

Abstract

Drug development is a long process that generally spans about 10 to 15 years. The shift in recent drug discovery to novel agents against specific molecular targets highlights the need for more robust molecular imaging platforms. Using molecular probes, molecular imaging can aid in many steps of the drug development process, such as providing whole body readout in an intact system, decreasing the workload and speeding up drug development/validation, and facilitating individualized anticancer treatment monitoring and dose optimization. The main focus of this review is the recent advances in tumor angiogenesis imaging, and the targets include vascular endothelial growth factor and vascular endothelial growth factor receptor, integrin {alpha}vß3, matrix metalloproteinase, endoglin (CD105), and E-selectin. Through tumor angiogenesis imaging, it is expected that a robust platform for understanding the mechanisms of tumor angiogenesis and evaluating the efficacy of novel antiangiogenic therapies will be developed, which can help antiangiogenic drug development in both the preclinical stage and the clinical settings. Molecular imaging has enormous potential in improving the efficiency of the drug development process, including the specific area of antiangiogenic drugs. [Mol Cancer Ther 2006;5(11):2624–33]


Footnotes

Grant support: National Institute of Biomedical Imaging and Bioengineering grant R21 EB001785; National Cancer Institute grants R21 CA102123, P50 CA114747, U54 CA119367, and R24 CA93862; Department of Defense grant W81XWH-04-1-0697, W81XWH-06-1-0665, W81XWH-06-1-0042, and DAMD17-03-1-0143; and Benedict Cassen Postdoctoral Fellowship from the Education and Research Foundation of the Society of Nuclear Medicine (W. Cai).

Received 7/10/06; revised 8/29/06; accepted 9/12/06.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Q. Cao, W. Cai, G. Niu, L. He, and X. Chen
Multimodality Imaging of IL-18-Binding Protein-Fc Therapy of Experimental Lung Metastasis
Clin. Cancer Res., October 1, 2008; 14(19): 6137 - 6145.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. T. Winnard Jr., A. P. Pathak, S. Dhara, S. Y. Cho, V. Raman, and M. G. Pomper
Molecular Imaging of Metastatic Potential
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 96S - 112S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Cai and X. Chen
Multimodality Molecular Imaging of Tumor Angiogenesis
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 113S - 128S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. R. Hsu and X. Chen
Advances in Anatomic, Functional, and Molecular Imaging of Angiogenesis
J. Nucl. Med., April 1, 2008; 49(4): 511 - 514.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. K. Willmann, R. Paulmurugan, K. Chen, O. Gheysens, M. Rodriguez-Porcel, A. M. Lutz, I. Y. Chen, X. Chen, and S. S. Gambhir
US Imaging of Tumor Angiogenesis with Microbubbles Targeted to Vascular Endothelial Growth Factor Receptor Type 2 in Mice
Radiology, February 1, 2008; 246(2): 508 - 518.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Cai, K. Chen, Z.-B. Li, S. S. Gambhir, and X. Chen
Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature
J. Nucl. Med., November 1, 2007; 48(11): 1862 - 1870.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.